Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biomarin Pharmaceuticals (NQ: BMRN )

82.97 USD +1.61 (+1.98%)
Official Closing Price Updated: 7:59 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Biomarin Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
82 83 Next >
NASDAQ:BMRN Long-Term Investor Notice: Investigation of Potential Wrongdoing at BioMarin Pharmaceutical Inc.
San Diego, CA -- (SBWIRE) -- 01/18/2021 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of BioMarin Pharmaceutical Inc.. 
From SBWire - Latest Press Releases
BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into BioMarin... 
From Business Wire News Releases
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Long Term Investor Notice: Investigation of Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 01/14/2021 -- Certain directors of BioMarin Pharmaceutical Inc are under investigation over potential breaches of fiduciary duties. 
From SBWire - Latest Press Releases
Noteworthy Monday Option Activity: PI, CROX, BMRN
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Impinj Inc (PI), where a total of 3,746 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Geovax Labs (NASDAQ:GOVX) shares rose 64.24% to $5.42 during Monday's regular session. Trading volume for ... 
Tags Movers MESO BZI/TFM
From Benzinga
BioMarin Announces Positive Phase 3 Gene Therapy Trial Results in Adults with Severe Hemophilia A; Study Met All Primary and Secondary Efficacy Endpoints in One-Year Data Set
- Significantly Reduced Mean Annualized Bleeding Rate by 84% (p-value <0.0001) Demonstrating Superiority to Factor VIII Prophylaxis, and Reduced Mean Annualized Factor VIII Infusion Rate by 99%... 
From PR Newswire
BioMarin Pharmaceutical Larger Than S&P 500 Component Waters
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component BioMarin Pharmaceutical Inc (BMRN) was identified as having a larger market cap than the smaller end of the... 
Tags Stocks
From Market News Video
BioMarin to Participate in Two Upcoming Virtual Investor Conferences
- Goldman Sachs 13th Annual Healthcare CEOs Unscripted Conference: A View from the Top on January 5 at 12:35pm ET 
From PR Newswire
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the ... 
Tags Health Care MRNA Benzinga
From Benzinga
Is Pfizer Stock A Buy On A New U.S. Supply Deal For Covid Vaccine?
U.S. officials inked a deal for 100 million more doses of Pfizer's coronavirus vaccine. That brings the total number of vaccine doses up to 200 million. So, is Pfizer stock a buy now? 
From Investor's Business Daily
Analysts Forecast 10% Gains Ahead For The Holdings of BBH
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
First Week of February 2021 Options Trading For BioMarin Pharmaceutical (BMRN)
Investors in BioMarin Pharmaceutical Inc (BMRN) saw new options begin trading this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
Nasdaq 100 Movers: TSLA, BIDU
In early trading on Monday, shares of Baidu topped the list of the day's best performing components of the Nasdaq 100 index, trading up 4.6%. Year to date, Baidu registers a 59.4% gain. 
Tags Stocks
From Market News Video
BioMarin Announces Benefit Maintained for Over Two Years in Children with Achondroplasia Treated with Vosoritide in Phase 3 Extension Study
Children Treated with Vosoritide Demonstrate Cumulative Height Gain of 3.52 cm at Year 2 Compared to Untreated Children 
From PR Newswire
4 Biotechs That Could Be Potential Acquisition Targets in 2021
Stocks of these companies have not fully recovered from the stock-market crash in March 2020, suggesting attractive valuations. 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Top Six Long-Term Earnings Growth Stocks
It seems that some stocks, especially IPOs and former SPACs, have been trading at nosebleed levels with no earnings whatsoever. At some point, investors will start to concentrate on the fundamentals. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Bitcoin Skyrockets Through All-time Highs As It Tops $22,000
Bitcoin is now the 13th-largest asset by market cap according to AssetDash and has a market cap of around $403 billion thanks to the latest price surge, making it nearly as valuable as US retail giant... 
Tags Services bitcoin Cryptocurrencies
From Blogs - TalkMarkets
What Traders Need To Know About The Historic S&P 500, Nasdaq 100 Rebalancing
Traders will be looking out for some major volatility in the markets in the coming days as part of significant rebalancing in both the ... 
Tags LBTYA TSLA Market News
From Benzinga
Interesting BMRN Put And Call Options For December 18th
Investors in BioMarin Pharmaceutical Inc (BMRN) saw new options become available this week, for the December 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
Nasdaq-100's Annual Reconstitution: Expedia and Citrix Out, Peloton and Marvell Technology In
Nasdaq Inc NDAQ​​​​​​​ 0.54% has announced the annual reconstitution of its Nasdaq-100 Index. The changes will go into effect on Dec. 21, prior to the market's open. The Nasdaq-100 Index lists the 100... 
Tags Stocks / Equities Pharma/Biotech Technology
From Blogs - TalkMarkets
Nasdaq-100's Annual Reconstitution: Expedia and Citrix Out, Peloton and Marvell Technology In
Nasdaq Inc(NASDAQ: NDAQ) has announced the annual reconstitution of its Nasdaq-100 Index. The changes will come into effect on ... 
Tags ULTA BMRN NASDAQ
From Benzinga
Annual Changes to the Nasdaq-100 Index
From GlobeNewswire News Releases
Is Pfizer Stock A Buy After FDA Promises To 'Rapidly' Authorize Covid Vaccine?
Pfizer stock was under pressure in mid-December as investors awaited a Food and Drug Administration decision over its BioNTech-partnered coronavirus vaccine. But is the stock a buy now? 
From Investor's Business Daily
Noteworthy Thursday Option Activity: CECE, GNW, BMRN
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in CECO Environmental Corp. (CECE), where a total of 954 contracts have traded so far,... 
Tags Stocks
From Market News Video
Should Investors Buy Moderna Stock for Its Coronavirus Vaccine?
Don't forget about the biotech's long-term valuation. 
Tags Market News MRNA EXEL
From Motley Fool
BioMarin to Participate in Two Upcoming Virtual Investor Conferences
- Piper Sandler 32nd Annual Virtual Healthcare Conference on December 2 at 3:00pm ET 
From PR Newswire
Is Pfizer Stock A Buy As It Sends Coronavirus Vaccine To The FDA?
Pfizer stock jumped in mid-November after the pharma company said it was "within days" of seeking emergency authorization for its coronavirus vaccine. But is the stock a buy now? 
From Investor's Business Daily
BMRN Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds BioMarin Pharmaceutical Inc. Investors With Losses Exceeding $100K of Class Action and Lead Plaintiff Deadline: November 24, 2020
From GlobeNewswire News Releases
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against BioMarin Pharmaceutical Inc. 
From Business Wire News Releases
BIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Ph
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until November 24, 2020 to file lead plaintiff... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
82 83 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account